Canada investing in COVID-19 vaccine manufacturing Description video: In addition to procuring vaccines from international pharmaceutical companies, the federal government is investing hundreds of millions of dollars in manufacturing facilities for COVID-19 vaccines and therapeutics that will be needed in […]
Canada investing in COVID-19 vaccine manufacturing
In addition to procuring vaccines from international pharmaceutical companies, the federal government is investing hundreds of millions of dollars in manufacturing facilities for COVID-19 vaccines and therapeutics that will be needed in the long term.\n\nTo read more: http://cbc.ca/news\n\n»»» Subscribe to CBC News to watch more videos: http://bit.ly/1RreYWS\n\nConnect with CBC News Online:\n\nFor breaking news, video, audio and in-depth coverage: http://bit.ly/1Z0m6iX\nFind CBC News on Facebook: http://bit.ly/1WjG36m\nFollow CBC News on Twitter: http://bit.ly/1sA5P9H\nFor breaking news on Twitter: http://bit.ly/1WjDyks\nFollow CBC News on Instagram: http://bit.ly/1Z0iE7O\nSubscribe to CBC News on Snapchat: https://bit.ly/3leaWsr\n\nDownload the CBC News app for iOS: http://apple.co/25mpsUz\nDownload the CBC News app for Android: http://bit.ly/1XxuozZ\n\n»»»»»»»»»»»»»»»»»»\nFor more than 75 years, CBC News has been the source Canadians turn to, to keep them informed about their communities, their country and their world. Through regional and national programming on multiple platforms, including CBC Television, CBC News Network, CBC Radio, CBCNews.ca, mobile and on-demand, CBC News and its internationally recognized team of award-winning journalists deliver the breaking stories, the issues, the analyses and the personalities that matter to Canadians.
Investors anticipating COVID-19 vaccine
Investors awaiting the release of the COVID-19 vaccine are starting to buy up shares in banks and industrial companies in anticipation of a surge in consumer confidence. However, many market participants remain fearful of risks in sectors devastated by the pandemic..
The emergence of any preventative drug is seen as the best chance to stop the coronavirus, which has killed 1.2 million people, and is a major concern for financial managers awaiting the next major market shift..
As the hype around the U.S. election subsides, investors brace for some good news about vaccines they think is just a matter of time..
«This will change a lot. When we get the vaccine, all pent-up demand will spill out.», – said Stuart Oakley, Head of Cash Trading at Nomura in London.
Of the approximately 45 vaccines in human trials, Pfizer projects, AstraZeneca and Moderna viewed as the most promising for regulatory approval this year.
Binai Chandgotia, a Hong Kong portfolio manager at Principal Global Investors noted that banks would benefit from increased economic activity and would be helped if bond yields rose. He also advises paying attention to the securities of small companies on the Hong Kong and Singapore exchanges if trade and tourism begin to gain momentum..
Brian Jacobsen, senior investment strategist at Wells Fargo Asset Management in Wisconsin, said industry offers a wide range of opportunities to rebuild confidence in areas such as construction and aviation.
Deutsche Bank operates «vaccine basket» of Singapore dollars and Thai baht, which are believed to benefit from increased trade and tourism, versus the Philippine peso, which is weighted by increased imports.
Industrial enterprises rallied with the broader market this month but lagged well behind global stocks gaining around 5% this year. Baht has also recently risen against the peso.